Sponsored Content
Peptide Aggregation – A Complex Topic [WATCH ON-DEMAND]
Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.
More Sponsored Content by Bachem
More Content From Bachem
-
Bachem will use all three events to showcase its leading-edge capabilities as a peptide and oligonucleotide manufacturer.
-
Join Bachem for a Virtual Event on Tuesday, December 5th, 2023.
-
Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate Synthesis
-
The webinar will take place on November 15, 2023 at 11:00 AM ET / 8:00 AM PT / 17:00 CET
-
Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.
-
The peptide drug market has experienced significant growth in recent years and is expected to continue its upward trend in the coming years.
-
In this webinar, Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.
-
Bachem Holding AG announced today that its Annual General Meeting 2023 has approved all proposals of the Board of Directors.
-
Gilles Parmentier is a seasoned Sales Manager with extensive experience in the field of peptides.
-
By 2026, Bachem wants to count a 10% higher proportion of women in its workforce, upper management and regional executive committees as compared to 2020.
-
Wednesday, May 24th, 2023 - 11:00 AM ET / 17:00 AM Europe/Zurich
-
Sunday, May 7th - Wednesday, May 10th, 2023 - All Day Event
-
It is currently used as an active pharmaceutical ingredient in prescription medicines for the treatment of type II diabetes and Obesity.
-
This tour is an exclusive walkthrough of Bachem’s oligonucleotide facilities in the company’s Headquarters, Bubendorf, Basel, Switzerland.
-
Peptides have the potential to expand the space of “druggable” targets.